Patents by Inventor Anne Eckert

Anne Eckert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL OMEGA-3 AND OMEGA-6 FATTY ACID COMPOSITIONS AND USES THEREOF
    Publication number: 20130230592
    Abstract: A composition for use in preventing and/or treating and/or reducing organic, including symptomatic, mental disorders, comprising: a) Docosahexaenoic acid (DHA) and/or the pharmaceutically acceptable derivatives and/or precursors thereof; b) Eicosapentaenoic acid (EPA) and/or the pharmaceutically acceptable derivatives and/or precursors thereof; c) ?-linolenic acid (GLA) and/or the pharmaceutically acceptable derivatives and/or precursors thereof; and at least one vitamin selected from vitamin B6, folic acid, vitamin B12, vitamin E, and/or vitamin D, at least one mineral which is selenium and/or zinc, optionally other vitamins, and optionally a polyphenolic plant extract with antioxidant properties.
    Type: Application
    Filed: April 12, 2013
    Publication date: September 5, 2013
    Inventors: Christian TERREAUX, Eleonora HOMBERGER, Burkhard KRIWET, Anne ECKERT
  • Transgeneic animal expressing a multiple mutated form of presenilin 1
    Patent number: 8492610
    Abstract: The present invention relates to the field of transgenic animal models and more particularly the animal models of Alzheimer's disease. The invention relates to a transgenic animal expressing a multimutated form of presenilin 1 and allowing an apoptotic phenomenon to be detected in a renewable peripheral tissue.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: July 23, 2013
    Assignee: Aventis Pharma S.A.
    Inventors: Anne Eckert, Walter Muller, Christian Czech, Laurent Pradier, Gunter Tremp